NCT03776942CompletedNot Applicable
Synovial Chondrosarcoma: a Single Institution Experience
Istituto Ortopedico Rizzoli1 site in 1 country9 target enrollmentStarted: August 7, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Enrollment
- 9
- Locations
- 1
- Primary Endpoint
- selection and review of cases of Synovial Chondrosarcoma
Study Overview
Brief Summary
single institution cases series review of histological, radiological and clinical data
Detailed Description
single institution cases series review of histological, radiological and clinical data. Investigators will retrieve from the archives of the Rizzoli institute all the cases with a histological diagnosis of synovial chondrosarcoma.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male and female patients treated at Rizzoli Institute from 01 January 1982 to 31 December 2017
- •Diagnosis of synovial chondrosarcoma
- •Age ≥ 18 years
- •Histological slides / formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis
- •Written informed consent prior to any study-specific analysis and/or data collection
Exclusion Criteria
- •Patients with histological diagnosis different from synovial chondrosarcoma
Outcomes
Primary Outcomes
selection and review of cases of Synovial Chondrosarcoma
Time Frame: baseline (Day0)
IDH1 and IDH2 analysis will be performed in order to better understand tumor characteristics and to identify the best therapeutic approach.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Periosteal Chondrosarcoma: a Single Institution ExperiencePeriosteal ChondrosarcomaNCT05511883Istituto Ortopedico Rizzoli55
Completed
Not Applicable
an Istitution Experience on Parosteal OsTeosarcomaParosteal OsteosarcomaNCT03768076Istituto Ortopedico Rizzoli220
Completed
Phase 2
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaDedifferentiated ChondrosarcomaConventional ChondrosarcomaMyxoid LiposarcomaMesenchymal ChondrosarcomaNCT02821507Leiden University Medical Center70
Recruiting
Not Applicable
Assessment of the Functional Outcome and Quality of Life in Sarcoma PatientsSoft Tissue SarcomaBone SarcomaNCT05051059Universitaire Ziekenhuizen KU Leuven60
Completed
Not Applicable
Low Grade Chondrosarcoma Versus EnchondromaChondromaChondrosarcomaNCT02996747Istituto Ortopedico Rizzoli102